MedPath

Lidothol

Lidothol - Lidocaine HCL 4.5%, Menthol 5% Gel

Approved
Approval ID

f18c6054-3020-64ec-e053-2995a90a57a0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2023

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine HCL and Menthol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0251
Product Classification
G
Generic Name
Lidocaine HCL and Menthol
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (2)

MENTHOLActive
Quantity: 5 g in 100 g
Code: L7T10EIP3A
Classification: ACTIB
LIDOCAINE HYDROCHLORIDEActive
Quantity: 4.5 g in 100 g
Code: V13007Z41A
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidothol - FDA Drug Approval Details